cs 834 has been researched along with Bacterial Infections in 2 studies
*Bacterial Infections: Infections by bacteria, general or unspecified. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Domon, H; Fukuoka, T; Harasaki, T; Hirasawa, A; Ishii, C; Iwata, M; Kakuta, M; Kawada, H; Koga, T; Kubota, M; Kuwahara, S; Masuda, N; Ohya, S; Sakagawa, E; Takenouchi, T; Utsui, Y; Yasuda, H | 1 |
| Nishino, T; Oh, T; Otsuki, M; Ou, T; Sakagawa, E | 1 |
2 other study(ies) available for cs 834 and Bacterial Infections
| Article | Year |
|---|---|
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Topics: Administration, Oral; Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Stability; Hexosyltransferases; Imipenem; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia, Staphylococcal; Prodrugs; Thienamycins | 1997 |
In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem.
Topics: Administration, Oral; Animals; Bacteria; Bacterial Infections; Bacterial Proteins; Carbapenems; Carrier Proteins; Colony Count, Microbial; Drug Resistance, Microbial; Escherichia coli; Hexosyltransferases; Male; Mice; Microbial Sensitivity Tests; Microscopy, Interference; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Prodrugs; Protein Binding | 1998 |